🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Therapeutic Effect of Electroacupuncture at Zusanli (ST-36) on Diabetic Foot Wounds

RecruitingNAAges 18 Years - 75 YearsAllZhongda Hospital
NCT07482137 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this clinical trial is to learn if electroacupuncture at the Zusanli (ST-36) can assist in the treatment of diabetic foot ulcers. The main question it aims to answer is: Can electroacupuncture at the Zusanli (ST-36) promote wound healing in patients with diabetic foot ulcers? Researchers will compare outcomes between participants receiving electroacupuncture plus standard treatment and those receiving standard treatment alone to assess the effect of Zusanli (ST36) stimulation on wound healing in patients with diabetic foot ulcers. Participants will: Receive standard diabetes treatment (including diabetes education, dietary control, insulin combined with oral hypoglycemic agents to manage blood glucose, and effective antibiotics to control infection. For patients with foot ulcers, the wound will be cleaned with saline; abscesses will be drained if present; daily dressing ch

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Meet the diagnostic criteria for diabetic foot ulcers; 2. Meet the criteria for Traditional Chinese Medicine syndrome differentiation, classified as blood stasis obstructing the collateral pattern; 3. Wagner Grade 1-3, with ulcer area ranging from 2 cm² to 30 cm²; 4. Male or female, aged between 18 and 75 years; 5. Provide signed informed consent, voluntarily participate in this study, and demonstrate good compliance. Exclusion Criteria: 1. Complicated with severe diseases of the brain, liver, heart, lungs, or kidneys; 2. Pregnant women or women planning to become pregnant; 3. Glycosylated hemoglobin (HbA1c) level ≥ 9%; 4. Complicated with psychiatric disorders; 5. Complicated with genetic or infectious diseases, malignant tumors, or other severe conditions associated with a short life expectancy; 6. Concurrent participation in other clinical trials or participation within 4 weeks prior to randomization.
💊

What it tests

  • Electroacupuncture at Zusanli (ST-36)
📍

Where

1 site
Zongda Hospital affiliated to Southeast University
Nanjing, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy